Kronos Advanced Technologies Inc. (OTC: KNOS) Air Purifier

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
355
Kronos Advanced Technologies Inc. (OTC: KNOS) Air Purifier Features Most Effective Technology Available

- Air purifiers can improve indoor air quality, help soothe allergy and asthma symptoms, and rid air of toxins.
- Kronos’s proprietary, medical-grade technology has been tested as the most effective clean-air solution on the market.
- An air purifier “may be the household investment to make this year” (“USA Today”)

The global pandemic has drawn attention to the fact that airborne particles can be dangerous, even life threatening. Kronos Advanced Technologies (OTC: KNOS) has developed one of the most effective air purifiers available today.

One study attributed over two million deaths annually to indoor air pollution (https://nnw.fm/afMbo). Air purifiers are part of the solution because they “greatly improve indoor air quality in large and small spaces alike,” reports a recent “USA Today” article (https://nnw.fm/RqQ7w).

“Indoor air pollution is a risk factor for several of the world’s leading causes of death, including heart disease, pneumonia, stroke, diabetes and lung cancer,” reports Our World in Data. “We see that it is one of the leading risk factors for death globally. According to the Global Burden of Disease study, 2.31 million deaths were attributed to indoor pollution in the latest year.”

The “USA Today” article concurs, noting that “air quality is a serious issue that has made headlines over the past year as concerns grow around filtering contaminants like wildfire particulate matter and viruses from the air we breathe. While wearing face masks to protect from the coronavirus is ever on the mind, the air quality of your home is often overlooked. Fuel-burning appliances, deteriorating insulation, newly installed carpets, household cleaning products and outdoor air pollution are just a few of the sources of unhealthy air quality inside, where you live, eat and sleep.”

The “USA Today” article points out that everything from asbestos and carbon monoxide to pesticides and lead can pollute stagnant household air, resulting in short- and long-term health problems. Issues arising from inadequate ventilation, the article explains, can range “from mild allergy-like symptoms to respiratory diseases and cancer.” Fortunately, “air purifiers can help remove or reduce pollutants by using a combination of physical filters, devices, chemicals and techniques. By doing so, air purifiers can improve the indoor air quality of your home, help soothe allergy and asthma symptoms, and get rid of toxins in the air.”

Thanks to the array of benefits provided by air purifiers, the air purifier market space is growing. A recent Grand View Research report noted that the U.S. air purifier market was estimated at $2.17 billion in 2020 and is expected to grow at a compound annual growth rate (“CAGR”) of 8.6% from 2020 to 2028. The article pointed to increasing pollution levels and the rising prevalence of airborne diseases in the nation as the reasons behind rising product demand (https://nnw.fm/jLZDw).

Kronos is making its presence felt in the growing sector with its proprietary, medical-grade technology, which has been tested as the most effective clean-air solution on the market. The Kronos AIR 5G filters particles down to .0146 micron, far beyond the 3 microns of a traditional HEPA filter. And Kronos air purifiers do more than collect air pollutants — using approximately 30,000 volts, the Kronos AIR 5G air purifier destroys 99.99% of all airborne bacteria, mold and virus particles.

“So, are air purifiers worth it?” “USA Today” asks. “The short answer is yes, because they work just as they’re intended. Several studies have shown that air purifier usage can have a mild to moderate positive effect on air quality and, therefore, personal health. For this reason, an air purifier may be the household investment to make this year.”

For more information about Kronos(R) AIR 5G(R) patented air-purifier technology and to purchase products, visit the company’s website at www.KronosATI.co.

NOTE TO INVESTORS: The latest news and updates relating to KNOS are available in the company’s newsroom at https://nnw.fm/KNOS

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer


Kronos Advanced Tech (KNOS) Stock Research Links

KNOS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 5

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 74

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 25

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 42

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Artprice Bridges Art and AI Across the Hispanic World

Updated Category News Views 11

A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...

Continue Reading
Tulsa Hosts Gradient's Global Tech and Investment Event

Updated Category News Views 21

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Continue Reading
SOPHiA GENETICS' Q3 2026: Revenue Growth & Challenges

Updated Category News Views 7

Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 13

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 89

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 160

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading

Top 5 Most Recently Viewed Articles

Rising Demand and Technological Advancements in Krill Meal Market

Updated Category News Views 226

Understanding the Expanding Krill Meal Market The krill meal market is undergoing remarkable growth, fueled by a shift in consumer preferences favoring clean-label food products and natural flavor enhancers. According to recent estimates, the market is poised to expand significantly, reaching an impressive valuation by the end of an upcoming decade. This growth can be...

Continue Reading
Tango Therapeutics Begins Dosing in Pivotal Cancer Trial

Updated Category News Views 224

Tango Therapeutics Begins Dosing in Pivotal Cancer Trial BOSTON — Tango Therapeutics, Inc. (NASDAQ: TNGX), a dynamic biotechnology company dedicated to revolutionizing cancer care, has achieved a pivotal milestone by dosing the first patient in its TNG456 Phase 1/2 trial aimed at patients with MTAP-deleted solid tumors, particularly glioblastoma (GBM). Known for its...

Continue Reading
Investors Invited to Explore Class Action against Rentokil Initial

Updated Category News Views 188

Investors Encouraged to Join Class Action Against Rentokil Initial Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm known for its expertise in securities cases, is reaching out to investors of Rentokil Initial Plc. This communication centers around a class action lawsuit that has been filed on behalf of those affected by some significant events concerning the...

Continue Reading
Murphy USA's Dividend Boost: A Commitment to Shareholders

Updated Category News Views 78

Murphy USA's Dividend Boost Reflects Confidence in Growth Murphy USA Inc. (NYSE: MUSA), a well-known player in the gasoline and convenience store sector, has recently announced an increase in its quarterly cash dividend. The company's Board has declared a new dividend of $0.48 per share, which represents a notable 6.7% rise from the previous dividend. This increase...

Continue Reading
Cloudinary Enhances Digital Asset Management with New Features

Updated Category News Views 181

Cloudinary's Innovative Update to Digital Asset Management Today, Cloudinary, the leading image and video platform, revealed significant advancements in its API-first digital asset management (DAM) solution. These enhancements are designed to address the evolving needs of brands in managing their visual assets efficiently and effectively. With a focus on streamlining...

Continue Reading